MC2 Therapeutics Receives Positive Feedback from FDA pre-IND Meeting and Updates on Indication Expansion Strategy tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Nexstim Oyj
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD
Press release, Helsinki, 16.04.2021, 12.00 pm (EEST)
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD
Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( Nexstim or Company ) announces that the company’s SmartFocus® nTMS technology used at Mind Matters Psychiatry MD, US has generated positive feedback from its use in treating patients with depression.
(0)
Press release, Helsinki, 16.04.2021, 12.00 pm (EEST)
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT Systems to Treat MDD
Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( Nexstim or Company ) announces that the company s SmartFocus nTMS technology used at Mind Matters Psychiatry MD, US has generated positive feedback from its use in treating patients with depression.
Oladele Adebogun M.D. said, I was initially introduced to Nexstim by the early outcomes of their registry which showed 50% remission rates in a small number of patients suffering from major depressive disorder. I purchased my first system and have been so impressed with my own patient outcomes that I have added this second system for my patients located in Flower Mound, Texas. I have even been able to successfully treat those patients who failed to respond to TMS on our prior non-Nexstim system. I am proud to contribute to the latest Nexstim treatment outcomes of triple the num